Preparing
to bring multiple new products to market, NutraNomics is a dietary supplement
research and development company that has been working on new formulations for
over 18 years. At the helm of NutraNomics is CEO Dr. Tracy Gibbs, who traveled
worldwide and studied the science of medicines derived from natural sources.
His particular expertise has been finding ways to treat diseases that may be
caused by or made worse by enzyme deficiencies. So, if you suffer from an
enzyme deficiency, your body is not properly extracting all the nutrients you
need from your food, and this can lead to a number of health problems.
Found in
all living cells, enzymes are large organic molecules that act as catalysts; in
other words they aid and increase the rates of biochemical reactions.
Specifically, the biochemical reactions are a necessary part of the breakdown
and regenerative process of life. Digestive enzymes break down the food we eat,
and the way we cook or process food may destroy the enzymes needed to break
down the food properly, thus taking enzyme supplements can aid in digesting
food. For example, the enzymes amylase, lipase, and protease are all produced
in the pancreas, and each plays a role in the digestive process: amylase in the
breakdown of carbohydrates, lipase in the breakdown of fats, and protease in
the breakdown of proteins. All three of these particular enzymes can also be
found in a number of raw fruits and vegetables, nuts, and grains.
One of the
primary innovations in NutraNomics product pipeline is its patented
Assimilation Enhancing System (AES) formulation. AES is a combination of
enzymes with mineral cofactors designed to enhance the activity and efficiency
of the enzymes. This ensures the AES is active throughout the digestive process
as well as in the blood stream. Protein, carbohydrates, and fats contained in a
product are completely hydrolyzed, which releases the vitamins, minerals, and
bioactive nutrients more readily, causing them to be assimilated in the body
quicker. This will also cause proteins to become more bio-available to the
body. Because AES has been shown to be absorbed by the bloodstream, science
also points to its ability to potentially lower triglyceride levels, blood
sugar levels, uric acid levels and cholesterol levels. So overall, AES improves
digestion, assimilation of nutrients, as well as overall heart health. The AES
Delivery System is included in many of NutraNomics’ proprietary supplements as
well as generates revenue through many licensing agreements. The company plans
to pursue additional licensing arrangements throughout 2014 to boost revenue
growth.
In 2013,
NutraNomics also purchased the exclusive marketing and distribution rights to a
natural therapeutic dietary supplement for use with cancer patients undergoing
chemotherapy. FDA Phase II clinical studies were completed in December of 2013
for patients undergoing treatment of prostrate cancer. The product, called
GenEpic, is formulated with 70 vitamins and minerals, 32 herbs, and 16 enzymes
and phytonutrients. Phytonutrients refer to a class of chemicals found in
plants that help protect plants from germs and fungal infections, and found to
have similar therapeutic benefits.
Another
product which had three separate case studies in 2013 is Glucozyme, a
nutritional supplement developed by NutraNomics to assist in the reduction of
blood glucose levels in patients with Type 2 diabetes. Essentially, by
addressing the body as a whole, one can regulate and then lower blood sugar
levels. Glucozyme is also being aggressively marketed this year, and a buyer in
Japan is expected to make significant purchases of this product.
Overall
from first quarter of 2013 compared to first quarter of 2014, sales in Japan
practically tripled. NutraNomics expects to continue growing its geographic
reach, and capture sales in the Philippines as well. Product sales from the
company’s own web site have seen organic growth with sales increasing by 82%
from the first quarter of 2014 compared to the fourth quarter of last year. The
global nutraceutical market is expected to grow to $204.8 billion by 2017, and
NutraNomics is certainly well positioned to capture its share.
For more
information about NutraNomics, visit: www.nutranomics.comP2 Solar, Inc. (PTOS)
Delivers on Demand for Clean, Renewable Energy through HydroPower
As the
benefits of producing electricity from mini-hydropower rise and overall
interest in the sector surging, governments worldwide are devoting time,
attention and resources to it. Positioned front and center, P2 Solar is a
company developing mini-hydropower projects for public and private sectors
seeking to include it into their electricity consumption profiles.
The appeal
of mini-hydropower is due to its ability to quickly respond to changing demand
for electricity, flood control and water management. Small and mini-hydropower
generation plants require two to five years to develop as compared to large
hydropower plants, which usually have a development period twice as long.
What’s more, small and mini-hydro has higher return on investment due to lower
capital investment, operational, maintenance and construction costs. Also worth
noting is that construction of a small hydropower plant is not as disruptive to
the local environment as large hydropower plants are.
In an
announcement last month, P2 Solar revealed that its subsidiary in India signed
a power purchase agreement with the Punjab energy distribution company for its
Rajgarh Mini-Hydro Project. This event is considered significant for the
company as its work leading to this point has involved years of effort. The
power purchase agreement involves payment terms of 35 years at a tariff of
approximately $0.10 USD. The company feels these terms provide for a high rate
of return and create cash flow free of cost. With this agreement P2 can close
bids for construction and advance to build the project.
P2 Solar’s
work is within the renewable energy market developing solar photovoltaic (PV)
power and mini-hydro projects. Understanding that the demand for clean,
renewable energy is rising due to commercial efforts to reduce reliance on
grid-produced electricity, P2 Solar is steering its efforts in a direction that
will enable it to benefit from this trend.
For more
information, visit www.p2solar.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment